<http://schema.org/description>
"(Reuters) - AstraZeneca Plc&amp;#039;s diabetes drug Onglyza may be associated with an increased rate of death, according to a preliminary review of data by the U.S. Food and Drug Administration. The"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2015/04/11/astrazenecas-diabetes-drug-onglyza-may-increase-death-rate-fda/21171074/>